Erschienen in:
04.03.2021 | Original Article
Circulating tumor cells after neoadjuvant chemotherapy are related with recurrence in esophageal squamous cell carcinoma
verfasst von:
Daisuke Ujiie, Takuro Matsumoto, Eisei Endo, Hirokazu Okayama, Shotaro Fujita, Yasuyuki Kanke, Yohei Watanabe, Hiroyuki Hanayama, Suguru Hayase, Zenichirou Saze, Shinji Ohki, Koji Kono
Erschienen in:
Esophagus
|
Ausgabe 3/2021
Einloggen, um Zugang zu erhalten
Abstract
Background
Circulating tumor cells (CTCs) are known to be a systemic process of malignant progression of cancer cells and there is a possibility that analysis for CTCs as a liquid biopsy become predictive or prognostic tools for cancer patients.
Methods
In the present study with the novel CTCs detection system (Celsee system®), we performed quantitative and qualitative analysis of CTCs in patients with esophageal squamous cell carcinoma (ESCC) receiving neoadjuvant chemotherapy (NAC) with 5FU + CDDP regimen. CTCs are defined as having both DAPI positive and CD45 negative. Vimentin-positive CTCs were defined as mesenchymal-type CTCs (M-CTCs), while epithelial-type CTCs (E-CTCs) were only positive for pan-cytokeratin.
Results
At the baseline, there are detectable amounts of CTCs in all patients (n = 30) at all stages, and there were no significant differences of total CTCs, E-CTCs, or M-CTCs numbers between stages. Of importance, among total CTCs, M-CTCs are more dominant than E-CTCs in number. Also, there was no significant change of detectable amounts and phenotype of CTCs before and after NAC (n = 24). Of note, early recurrent group indicated that there was an elevated total CTCs number before NAC and an increased M-CTCs after NAC in comparison to those in non-recurrent group.
Conclusions
Quantitative and qualitative analysis of CTCs may provide useful complementary predictive and prognostic information in ESCC.